keyword
https://read.qxmd.com/read/38561609/the-neem-limonoid-nimbolide-modulates-key-components-of-the-dna-damage-response-signalling-in-cellular-and-animal-models-of-oral-squamous-cell-carcinoma
#1
JOURNAL ARTICLE
Soundararajan Arvindh, Manashi Priyadarshini, Abdul Basit Baba, Veeran Veeravarmal, Rajakishore Mishra, Rupesh Dash, Siddavaram Nagini
BACKGROUND: A deregulated DNA damage response (DDR) network is implicated in cancer progression and therapy resistance. OBJECTIVE: The present study was designed to investigate whether nimbolide, an anticancer neem limonoid, targets key components of the DDR signalling pathway in cellular and animal models of oral squamous cell carcinoma (OSCC). METHODS: OSCC cells (SCC-4 and SCC-9), 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinoma model, chemoresistant OSCC patient-derived xenograft (PDX) model established in athymic nude mice, and tissue sections from patients with oral premalignant/malignant disease were used for the study...
March 28, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38530432/chemotherapy-initiated-cysteine-rich-protein-61-decreases-acute-b-lymphoblastic-leukemia-chemosensitivity
#2
JOURNAL ARTICLE
Pengchong Shi, Zhen Lin, Yanfang Song, Zhaozhong Li, Menglu Zeng, Li Luo, Yingping Cao, Xianjin Zhu
PURPOSE: Chemoresistance is a major challenge for acute lymphoblastic leukemia (ALL) treatment. Cysteine-rich protein 61 (Cyr61) plays an important role in drug resistance modulation of tumor cells, and Cyr61 levels are increased in the bone marrow of patients with ALL and contribute to ALL cell survival. However, the effect of Cyr61 on B cell acute lymphoblastic leukemia (B-ALL) cell chemosensitivity and the regulatory mechanisms underlying Cyr61 production in bone marrow remain unknown...
March 26, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38318173/hepatitis-b-surface-antigen-positivity-is-associated-with-poor-short-and-long-term-outcomes-in-patients-with-diffuse-large-b-cell-lymphoma-who-received-chop-or-r-chop
#3
JOURNAL ARTICLE
Zhumei Zhan, Wei Guo, Xin Wan, Bowen Wang, Jia Li, Haotian Wang, Zhe Li, Yuhua Huang, Ken H Young, Ou Bai
OBJECTIVE: The development of diffuse large B-cell lymphoma (DLBCL) is closely related to the host infection status. China is a highly endemic area for hepatitis B virus (HBV) infection. It is not clear whether HBV infection has a consistent effect on the prognostic implications of patients with DLBCL in different treatment settings. MATERIALS AND METHODS: We conducted a cohort study of 692 patients with DLBCL receiving three or more cycles of treatment with a CHOP or R-CHOP regimen from the First Hospital of Jilin University between July 2011 and July 2022...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38228147/tolerance-to-colibactin-correlates-with-homologous-recombination-proficiency-and-resistance-to-irinotecan-in-colorectal-cancer-cells
#4
JOURNAL ARTICLE
Alberto Sogari, Emanuele Rovera, Gaia Grasso, Elisa Mariella, Nicole Megan Reilly, Simona Lamba, Gianluca Mauri, Erika Durinikova, Pietro Paolo Vitiello, Annalisa Lorenzato, Marco Avolio, Eleonora Piumatti, Emanuela Bonoldi, Maria Costanza Aquilano, Sabrina Arena, Andrea Sartore-Bianchi, Salvatore Siena, Livio Trusolino, Manuela Donalisio, Mariangela Russo, Federica Di Nicolantonio, David Lembo, Alberto Bardelli
The bacterial genotoxin colibactin promotes colorectal cancer (CRC) tumorigenesis, but systematic assessment of its impact on DNA repair is lacking, and its effect on response to DNA-damaging chemotherapeutics is unknown. We find that CRC cell lines display differential response to colibactin on the basis of homologous recombination (HR) proficiency. Sensitivity to colibactin is induced by inhibition of ATM, which regulates DNA double-strand break repair, and blunted by HR reconstitution. Conversely, CRC cells chronically infected with colibactin develop a tolerant phenotype characterized by restored HR activity...
January 8, 2024: Cell reports medicine
https://read.qxmd.com/read/38128537/metabolic-regulation-of-homologous-recombination-repair-by-mre11-lactylation
#5
JOURNAL ARTICLE
Yuping Chen, Jinhuan Wu, Linhui Zhai, Tingting Zhang, Hui Yin, Huanyao Gao, Fei Zhao, Zhe Wang, Xiaoning Yang, Mingpeng Jin, Bingsong Huang, Xin Ding, Rui Li, Jie Yang, Yiming He, Qianwen Wang, Weibin Wang, Jake A Kloeber, Yunxuan Li, Bingbing Hao, Yuanyuan Zhang, Jiadong Wang, Minjia Tan, Ke Li, Ping Wang, Zhenkun Lou, Jian Yuan
Lactylation is a lactate-induced post-translational modification best known for its roles in epigenetic regulation. Herein, we demonstrate that MRE11, a crucial homologous recombination (HR) protein, is lactylated at K673 by the CBP acetyltransferase in response to DNA damage and dependent on ATM phosphorylation of the latter. MRE11 lactylation promotes its binding to DNA, facilitating DNA end resection and HR. Inhibition of CBP or LDH downregulated MRE11 lactylation, impaired HR, and enhanced chemosensitivity of tumor cells in patient-derived xenograft and organoid models...
January 18, 2024: Cell
https://read.qxmd.com/read/37977350/elevated-2-oxoglutarate-antagonizes-dna-damage-responses-in-cholangiocarcinoma-chemotherapy-through-regulating-aspartate-beta-hydroxylase
#6
JOURNAL ARTICLE
Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R Wands, Chiung-Kuei Huang
Cholangiocarcinoma (CCA) is resistant to systemic chemotherapies that kill malignant cells mainly through DNA damage responses (DDRs). Recent studies suggest that the involvement of 2-oxoglutarate (2-OG) dependent dioxygenases in DDRs may be associated with chemoresistance in malignancy, but how 2-OG impacts DDRs in CCA chemotherapy remains elusive. We examined serum 2-OG levels in CCA patients before receiving chemotherapy. CCA patients are classified as progressive disease (PD), partial response (PR), and stable disease (SD) after receiving chemotherapy...
November 15, 2023: Cancer Letters
https://read.qxmd.com/read/37930002/zinc-finger-proteins-and-atp-binding-cassette-transporter-dependent-multidrug-resistance
#7
REVIEW
Sanaz Barzegar, Saeed Pirouzpanah
BACKGROUND: Multidrug resistance (MDR) remains a significant challenge in cancer treatment, leading to poor clinical outcomes. Dysregulation of ATP-binding cassette (ABC) transporters has been identified as a key contributor to MDR. Zinc finger proteins (ZNPs) are key regulators of transcription and have emerged as potential contributors to cancer drug resistance. Bridging the knowledge gap between ZNPs and MDR is essential to understand a source of heterogeneity in cancer treatment. This review sought to elucidate how different ZNPs modulate the transcriptional regulation of ABC genes, contributing to resistance to cancer therapies...
November 6, 2023: European Journal of Clinical Investigation
https://read.qxmd.com/read/37835430/expression-and-activity-of-the-nf-%C3%AE%C2%BAb-subunits-in-chronic-lymphocytic-leukaemia-a-role-for-relb-and-non-canonical-signalling
#8
JOURNAL ARTICLE
Evan A Mulligan, Susan J Tudhope, Jill E Hunter, Arabella E G Clift, Sarah L Elliott, Geoffrey P Summerfield, Jonathan Wallis, Chris J Pepper, Barabara Durkacz, Stephany Veuger, Elaine Willmore
BACKGROUND: Canonical NF-κB signalling by p65 (RelA) confers chemo-resistance and poor survival in chronic lymphocytic leukaemia (CLL). The role of non-canonical NF-κB signalling (leading to RelB and p52 subunit activation) in CLL is less understood, but given its importance in other B-cell tumour types, we theorised that RelB and p52 may also contribute to the pathology of CLL. METHODS: DNA binding activity of all five NF-kB subunits, p65, p50, RelB, p52, and c-Rel, was quantified using ELISA and correlated to ex vivo chemoresistance, CD40L-stimulated signalling (to mimic the lymph node microenvironment), and clinical data...
September 26, 2023: Cancers
https://read.qxmd.com/read/37674118/reduced-expression-of-phosphorylated-ataxia-telangiectasia-mutated-gene-is-related-to-poor-prognosis-and-gemcitabine-chemoresistance-in-pancreatic-cancer
#9
JOURNAL ARTICLE
Jingyu Xun, Hideo Ohtsuka, Katsuya Hirose, Daisuke Douchi, Shun Nakayama, Masaharu Ishida, Takayuki Miura, Kyohei Ariake, Masamichi Mizuma, Kei Nakagawa, Takanori Morikawa, Toru Furukawa, Michiaki Unno
BACKGROUND: Loss of expression of the gene ataxia-telangiectasia mutated (ATM), occurring in patients with multiple primary malignancies, including pancreatic cancer, is associated with poor prognosis. In this study, we investigated the detailed molecular mechanism through which ATM expression affects the prognosis of patients with pancreatic cancer. METHODS: The levels of expression of ATM and phosphorylated ATM in patients with pancreatic cancer who had undergone surgical resection were analyzed using immunohistochemistry staining...
September 6, 2023: BMC Cancer
https://read.qxmd.com/read/37627905/establishment-and-characterization-of-multi-drug-resistant-p53-negative-osteosarcoma-saos-2-subline
#10
JOURNAL ARTICLE
Sergei Boichuk, Firyuza Bikinieva, Elena Valeeva, Pavel Dunaev, Maria Vasileva, Pavel Kopnin, Ekaterina Mikheeva, Tatyana Ivoilova, Ilshat Mustafin, Aigul Galembikova
AIM: To establish a p53-negative osteosarcoma (OS) SaOS-2 cellular subline exhibiting resistance to specific chemotherapeutic agents, including topoisomerase II inhibitors, taxanes, and vinca alkaloids. METHODS: The OS subline exhibiting resistance to the chemotherapeutic agents indicated above was generated by the stepwise treatment of the parental SaOS-2 cell line with increasing concentrations of doxorubicin (Dox) for 5 months. Half-inhibitory concentrations (IC50 ) for Dox, vinblastine (Vin), and paclitaxel (PTX) were calculated by a colorimetric MTS-based assay...
August 11, 2023: Diagnostics
https://read.qxmd.com/read/37606165/tpp1-inhibits-dna-damage-response-and-chemosensitivity-in-esophageal-cancer
#11
JOURNAL ARTICLE
Jilin Wen, Xiaowu Zhong, Chuanli Gao, Miyuan Yang, Maoju Tang, Zichun Yuan, Qin Wang, Lei Xu, Qiang Ma, Xiaolan Guo, Li Fang
TPP1, as one of the telomere-protective protein complex, functions to maintain telomere stability. In this study, we found that TPP1 was significantly upregulated in esophageal cancer (EC). We found that the proliferation and migration ability were significantly inhibited, while the results of flow cytometry assay indicated that the growth was hindered in the G1 phase after TPP1 knockdown. However, the proliferative viability and migratory ability were reversed after TPP1 overexpression in EC cells. Then, we found a significant increase in β-galactosidase positivity following TPP1 knockdown and the opposite following TPP1 overexpression in EC cells...
2023: Critical Reviews in Eukaryotic Gene Expression
https://read.qxmd.com/read/37475161/rutin-is-a-potent-senomorphic-agent-to-target-senescent-cells-and-can-improve-chemotherapeutic-efficacy
#12
JOURNAL ARTICLE
Hanxin Liu, Qixia Xu, Halidan Wufuer, Zi Li, Rong Sun, Zhirui Jiang, Xuefeng Dou, Qiang Fu, Judith Campisi, Yu Sun
Aging is a major risk factor for most chronic disorders, for which cellular senescence is one of the central hallmarks. Senescent cells develop the pro-inflammatory senescence-associated secretory phenotype (SASP), which significantly contributes to organismal aging and age-related disorders. Development of senotherapeutics, an emerging class of therapeutic agents to target senescent cells, allows to effectively delay aging and alleviate chronic pathologies. Here we report preliminary outputs from screening of a natural medicinal agent (NMA) library for senotherapeutic candidates and validated several agents with prominent potential as senomorphics...
July 20, 2023: Aging Cell
https://read.qxmd.com/read/37240218/dna-repair-pathway-in-ovarian-cancer-patients-treated-with-hipec
#13
JOURNAL ARTICLE
Dominika Flasarova, Katerina Urban, Ondrej Strouhal, Dusan Klos, Radmila Lemstrova, Pavel Dvorak, Pavel Soucek, Beatrice Mohelnikova-Duchonova
DNA repair pathways are essential for maintaining genome stability, and understanding the regulation of these mechanisms may help in the design of new strategies for treatments, the prevention of platinum-based chemoresistance, and the prolongation of overall patient survival not only with respect to ovarian cancer. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) together with cytoreductive surgery (CRS) and adjuvant systemic chemotherapy is receiving more interest in ovarian cancer (OC) treatment because of the typical peritoneal spread of the disease...
May 17, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36932195/loss-of-eps8-sensitizes-non-small-cell-lung-carcinoma-to-chemotherapy-induced-dna-damage
#14
JOURNAL ARTICLE
Yingqi Qiu, Binyan Xu, Jianhua Feng, Chunsheng Wang, Yiran Chen, Yanjie He, Xiaoling Xie, Yuhua Li
Epidermal growth factor receptor pathway substrate number 8 (EPS8) has been reported to be critical in mediating tumor progression. However, the molecular and biological consequences of EPS8 overexpression remain unclear. Here we evaluated whether EPS8 increased DNA damage repair in non-small-cell lung carcinoma (NSCLC) cells and the mechanism of EPS8-mediated DNA damage repair which influenced chemosensitivity. Serial studies of functional experiments revealed that EPS8 knockdown inhibited cell growth, induced cell-cycle arrest and increased cisplatin therapeutic effects on NSCLC...
March 17, 2023: Cancer Gene Therapy
https://read.qxmd.com/read/36923082/e2f1-inhibits-cellular-senescence-and-promotes-oxaliplatin-resistance-in-colorectal-cancer
#15
JOURNAL ARTICLE
Haiyang Gao, Fangyuan Zhou, Runze Li, Jiao Yuan, Lin Ye
BACKGROUND: Doctors have always been overwhelmed by tumor drug resistance because it is a major challenge in the clinical treatment of tumors. Cellular senescence has a strong relationship with the development of tumor drug resistance. Herein, we aimed to explore new regulatory factors involved in the aging process of colorectal cancer (CRC) cells and assess the effect of cellular senescence on CRC drug resistance. METHODS: Genes associated with cellular senescence for anticipating regulatory factors were first used, and the regulatory molecules of survival significance were then identified based on the results of public database analysis...
February 28, 2023: Annals of Translational Medicine
https://read.qxmd.com/read/36765888/2-2-diphenethyl-isothiocyanate-enhances-topoisomerase-inhibitor-induced-cell-death-and-suppresses-multi-drug-resistance-1-in-breast-cancer-cells
#16
JOURNAL ARTICLE
Monika Aggarwal
We previously reported that phenethyl isothiocyanate (PEITC), a dietary-related compound, can rescue mutant p53. A structure-activity relationships study showed that the synthetic analog 2,2-diphenylethyl isothiocyanate (DPEITC) is a more potent inducer of apoptosis than natural or synthetic ITCs. Here, we showed that DPEITC inhibited the growth of triple-negative breast cancer cells (MDA-MB-231, MDA-MB-468, and Hs578T) expressing "hotspot" p53 mutants, structural (p53R280K , p53R273H ) or contact (p53V157F ), at IC50 values significantly lower than PEITC...
February 1, 2023: Cancers
https://read.qxmd.com/read/36760254/elevated-adam-like-decysin-1-adamdec1-expression-is-associated-with-increased-chemo-sensitivity-and-improved-prognosis-in-breast-cancer-patients
#17
JOURNAL ARTICLE
Na Chai, Peilin Xie, Heyan Chen, Yijun Li, Yuting Zhao, Jianjun He, Huimin Zhang
BACKGROUND: Chemoresistance is problematic and its mechanisms are unclear in breast cancer. More predictive markers are urgently required. METHODS: GSE32646, GSE34138, and GSE20271 were downloaded from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs) between chemosensitive and chemoresistant tumors. LinkedOmics was used to analyze ADAM-like Decysin-1 (ADAMDEC1) expression among patients with different clinical characteristics and detect co-expression genes for functional analysis...
January 15, 2023: Annals of Translational Medicine
https://read.qxmd.com/read/36725890/bmal1-collaborates-with-clock-to-directly-promote-dna-double-strand-break-repair-and-tumor-chemoresistance
#18
JOURNAL ARTICLE
Canfeng Zhang, Liping Chen, Lu Sun, Heping Jin, Kai Ren, Shiqi Liu, Yongyu Qian, Shupeng Li, Fangping Li, Chengming Zhu, Yong Zhao, Haiying Liu, Yan Liu
Accumulating evidence indicates a correlation between circadian dysfunction and genomic instability. However, whether the circadian machinery directly regulates DNA damage repair, especially in double-strand breaks (DSBs), remains poorly understood. Here, we report that in response to DSBs, BMAL1 is activated by ATM-mediated phosphorylation at S183. Phosphorylated BMAL1 is then localized to DNA damage sites, where it facilitates acetylase CLOCK to load in the chromatin, regulating the acetylation of histone H4 (H4Ac) at DSB sites...
February 2, 2023: Oncogene
https://read.qxmd.com/read/36672401/dna-damage-response-alterations-in-ovarian-cancer-from-molecular-mechanisms-to-therapeutic-opportunities
#19
REVIEW
María Ovejero-Sánchez, Rogelio González-Sarmiento, Ana Belén Herrero
The DNA damage response (DDR), a set of signaling pathways for DNA damage detection and repair, maintains genomic stability when cells are exposed to endogenous or exogenous DNA-damaging agents. Alterations in these pathways are strongly associated with cancer development, including ovarian cancer (OC), the most lethal gynecologic malignancy. In OC, failures in the DDR have been related not only to the onset but also to progression and chemoresistance. It is known that approximately half of the most frequent subtype, high-grade serous carcinoma (HGSC), exhibit defects in DNA double-strand break (DSB) repair by homologous recombination (HR), and current evidence indicates that probably all HGSCs harbor a defect in at least one DDR pathway...
January 10, 2023: Cancers
https://read.qxmd.com/read/36660610/smc4-enhances-the-chemoresistance-of-hepatoma-cells-by-promoting-autophagy
#20
JOURNAL ARTICLE
Shi-Ran Zhang, Jie Li, Jing-Xiang Chen, Geng Chen, Jun-Ying Chen, Hang-Wei Fu, Bo Zhou
BACKGROUND: Drug resistance is a major contributing factor to chemotherapy failure in hepatocellular carcinoma (HCC) patients. However, the exact mechanism underlying the chemoresistance of HCC remains unknown. METHODS: HepG2 cells were incubated with different concentrations of 5-fluorouracil (5-FU), and the Cell Counting Kit-8 assay was used to test the cell survival rate. The expression level of structural maintenance of chromosome 4 (SMC4) in drug-resistant cells was analyzed by real-time quantitative polymerase chain reaction (PCR) and western blotting...
December 2022: Annals of Translational Medicine
keyword
keyword
58049
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.